Not another steroid trial: early low-dose hydrocortisone in preterm infants

Affiliations

¹ Department of Pediatrics, Sainte-Justine University Hospital Research Center, Faculty of Medicine, Université de Montréal, Montreal H3T 1C5, QC, Canada. Electronic address: anne-monique.nuyt@recherche-ste-justine.qc.ca.
² Department of Pediatrics, Ottawa Hospital Research Institute, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.

Comment

Anne Monique Nuyt et al. Lancet. 2016.

. 2016 Apr 30;387(10030):1793-4.

doi: 10.1016/S0140-6736(16)00503-1. Epub 2016 Feb 23.

¹ Department of Pediatrics, Sainte-Justine University Hospital Research Center, Faculty of Medicine, Université de Montréal, Montreal H3T 1C5, QC, Canada. Electronic address: anne-monique.nuyt@recherche-ste-justine.qc.ca.
² Department of Pediatrics, Ottawa Hospital Research Institute, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.

No abstract available

Comment on

Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial.
Baud O, Maury L, Lebail F, Ramful D, El Moussawi F, Nicaise C, Zupan-Simunek V, Coursol A, Beuchée A, Bolot P, Andrini P, Mohamed D, Alberti C; PREMILOC trial study group. Baud O, et al. Lancet. 2016 Apr 30;387(10030):1827-36. doi: 10.1016/S0140-6736(16)00202-6. Epub 2016 Feb 23. Lancet. 2016. PMID: 26916176 Clinical Trial.